An Exploratory Study of Physician Decision-Making When Treating Uncontrolled COPD

Area of Science:

• Pulmonary Medicine
• Healthcare Management

Background:

• Current guidelines advocate for triple therapy inhalers for chronic obstructive pulmonary disease (COPD) patients with recurrent exacerbations.
• Underutilization of recommended maintenance therapies in COPD management is a significant clinical challenge.

Purpose of the Study:

• To investigate physician decision-making processes regarding COPD treatment.
• To understand the real-world utilization patterns of combination maintenance therapies for COPD.

Main Methods:

• An exploratory, cross-sectional online survey was conducted with 200 US physicians.
• The survey utilized five patient vignettes and analyzed factors influencing treatment decisions and prescribing barriers.
• Multivariable analyses assessed the likelihood of switching to triple therapy versus maintaining current treatment.

Main Results:

• Treatment cost and patient access were identified as primary barriers to prescribing.
• Physicians were more inclined to switch to triple therapy based on patient history, insurance, and guidelines.
• Increased physician experience in COPD correlated with a higher likelihood of prescribing triple therapy.

Conclusions:

• Physician prescribing for COPD involves multifaceted considerations including cost, access, adherence, comorbidities, efficacy, guidelines, and experience.
• Further research is needed to clarify the importance of these factors and develop beneficial decision-support tools for COPD treatment.